Yıl: 2022 Cilt: 47 Sayı: 3 Sayfa Aralığı: 23 - 31 Metin Dili: İngilizce DOI: 10.1515/tjb-2021-0172 İndeks Tarihi: 05-05-2023

Thiol/disulfide homeostasis and oxidant status in children with congenital heart disease

Öz:
Objectives: This article aims to explain the altered oxida- tive status and thiol/disulfide homeostasis before and after surgery in children with congenital heart disease (CHD). Methods: Blood samples were taken from the patients (n=50) before the operation (baseline), at the 1st hour, and at the 24th hour after the operation. Thiol-disulfide levels, total antioxidant status (TAS), total oxidant status (TOS), oxida- tive stress index (OSI), myeloperoxidase (MPO), cerulo- plasmin, albumin, ischemia-modified albumin (IMA), and prolidase activities of all samples were measured. Pre- operative oxygen saturation (SaO2) values and neutrophil/ lymphocyte ratios (NLR) were also measured. Results: Before the operation, TOS, OSI, MPO, cerulo- plasmin, IMA, NRL, and disulfide levels were higher in the cyanotic group than in the acyanotic group. When the indicated three different time points were compared, the TOS, OSI levels, and MPO activities of the 24th hour were significantly lower than the baseline and 1st hour. In comparison, ceruloplasmin levels of 1st hour were signifi- cantly higher than of the baseline and 24th hour. Native thiol and total thiol levels in the baseline group were significantly lower than in the 1st and 24th hours. Disulfide levels of the 24th hour were significantly lower than of the baseline. Conclusions: The operation leads to changes in the thiol- disulfide balance and oxidant status in CHD.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Engineer A, Saiyin T, Greco ER, Feng Q. Say NO to ROS: their roles in embryonic heart development and pathogenesis of congenital heart defects in maternal diabetes. Antioxidants 2019;8:436.
  • Desborough JP. The stress response to trauma and surgery. Br J Anaesth 2000;851:109–17.
  • Laffey JG, Boylan JF, Cheng DCH. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 2002;97:215–52.
  • Atay Y, Atay A, Ayik MF, Isleten F, Koseoglu M, Oguz E, et al. Antioxidant response after the operations for congenital heart diseases. Turkish J Thorac Cardiovasc Surg 2012;20:722–8.
  • Altin FH, Yildirim HA, Tanidir IC, Yildiz O, Kahraman MZ, Ozturk E, et al. Alterations in antioxidant and oxidant status of children after on-pump surgery for cyanotic and acyanotic congenital heart diseases. Cardiol Young 2017;27:325–32.
  • Sogut I, Oglakci A, Kartkaya K, Ol KK, Sogut MS, Kanbak G, et al. Effect of boric acid on oxidative stress in rats with fetal alcohol syndrome. Exp Ther Med 2015;9:1023–7.
  • Sogut I, Senat A, Ilhan AO, Sezen A, Erel O. Evaluation of thiol/ disulfide homeostasis and other oxidative stress markers in patients undergoing hemodialysis. Turkish J Nephrol 2021;30: 17–24.
  • Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation:estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206–9.
  • Siotto M, Pasqualetti P, Marano M, Squitti R. Automation of o-dianisidine assay for ceruloplasmin activity analyses: usefulness of investigation in Wilson’s disease and in hepatic encephalopathy. J Neural Transm 2014;121:1281–6.
  • Das M, Cevik Y, Erel O, Corbacioglu SK. Ischemia-modified albumin levels in the prediction of acute critical neurological findings in carbon monoxide poisoning. Kaohsiung J Med Sci 2016;32:201–6.
  • Myara I, Myara A, Mangeot M, Fabre M, Charpentier C, Lemonnier A. Plasma prolidase activity:a possible index of collagen catabolism in chronic liver disease. Clin Chem 1984;30:211–5.
  • Erel O, Neselioglu S. A novel and automated assay for thiol/ disulphide homeostasis. Clin Biochem 2014;47:326–32.
  • Puri K, Allen HD, Qureshi AM. Congenital heart disease. Pediatr Rev 2017;38:471–86.
  • Pirinccioglu AG, Alyan O, Kizil G, Kangin M, Beyazit N. Evaluation of oxidative stress in children with congenital heart defects. Pediatr Int 2012;54:94–8.
  • Ercan S, Cakmak A, Kösecik D, Erel O. The oxidative state of children with cyanotic and acyanotic congenital heart disease. Anatol J Cardiol 2009;9:486–90.
  • Ramachandra CJA, Ja KPMM, Chua J, Cong S, Shim W, Hausenloy DJ. Myeloperoxidase as a multifaceted target for cardiovascular protection. Antioxidants Redox Signal 2020; 32:1135–49.
  • Sacheat HK, Husseinand SZ, Al-Mudhaffar SS. Evaluation of Ceruloplasmin ferroxidase activity and lipid profiles in patients with Valvular heart diseases. J Phys: Conf Ser; Bristol 2021; 1879:1–7.
  • Dervisoglu P, Oner T. Usefulness of ischemia-modified albumin for assessment of the effects of small ventricular septal defects on the pulmonary vascular bed. Cardiol Young 2021;31:1207–12.
  • Manuel V, Miana LA, Solla DJF, Fernandes N, Carrillo G, Jatene MB. Preoperative level of neutrophil-lymphocyte ratio: comparison between cyanotic and cyanotic congenital heart disease. J Card Surg 2021;36:1376–80.
  • Yildiz A, Demirbag R, Yilmaz R, Gur M, Altiparmak IH, Akyol S, et al. The association of serum prolidase activity with the presence and severity of coronary artery disease. Coron Artery Dis 2008;19:319–25.
  • Aslan M, Duzenli U, Esen R, Usul Soyoral Y. Serum prolidase enzyme activity in obese subjects and its relationship with oxidative stress markers. Clin Chim Acta 2017;473:186–90.
  • Cakmak A, Zeyrek D, Atas A, Celik H, Aksoy N, Erel O. Serum prolidase activity and oxidative status in patients with bronchial asthma. J Clin Lab Anal 2009;23:132–8.
  • Temel MT, Demiryurek S, Saracaloglu A, Ozer CH, Kahraman HN, Coskun ME, et al. Determination of dynamic thiol/disulphide homeostasis in children with tetralogy of Fallot and ventricular septal defect. Cardiol Young 2019;29:499–504.
  • Hadley S, Vazquez DC, Abad ML, Congiu S, Lushchencov D, Camprubi MC, et al. Oxidative stress response in children undergoing cardiac surgery: utility of the clearance of isoprostanes. PLoS One 2021;16:e0250124.
  • Fudulu D, Angelini G. Oxidative stress after surgery on the immature heart. Oxid Med Cell Longev 2016;2016:1971452.
  • Torres-Cuevas I, Parra-LIorca A, Sanchez-Illana A, Nunez-Ramiro A, Kuligowski J, Chafer-Pericas C, et al. Oxygen and oxidative stress in the perinatal period. Redox Biol 2017;12:674–81.
  • Kanko M, Yavuz S, Duman C, Hosten T, Oner E, Berki T. Ischemia- modified albumin use as a prognostic factor in coronary bypass surgery. J Cardiothorac Surg 2012;7:1–5.
  • Bakuy V, Gursoy M, Hokenek F, Gedikbasi A, Atay M, Nurdag A, et al. Prolidase activity in patients with coronary artery aneurysm. Angiology 2014;65:574–9.
  • Sanri US, Ozsin KK, Toktas F, Balci AB, Ustundag Y, Huysal K, et al. The effect of thiol-disulfide homeostasis in patients undergoing on-pump coronary artery bypass grafting. Turkish J Thorac Cardiovasc Surg 2019;27:484–92.
  • Molicki JS, Draaisma AM, Verbeet N, Munneke R, Huysmans HA, Hazekamp MG, et al. Prime solutions for cardiopulmonary bypass in neonates: antioxidant capacity of prime based on albumin or fresh frozen plasma. J Thorac Cardiovasc Surg 2001; 122:449–56.
APA Sogut I, KAR F, ŞENAT A, Duymaz T, EREL O, Salihoglu E (2022). Thiol/disulfide homeostasis and oxidant status in children with congenital heart disease. , 23 - 31. 10.1515/tjb-2021-0172
Chicago Sogut Ibrahim,KAR FATİH,ŞENAT Almila,Duymaz Tomris,EREL Ozcan,Salihoglu Ece Thiol/disulfide homeostasis and oxidant status in children with congenital heart disease. (2022): 23 - 31. 10.1515/tjb-2021-0172
MLA Sogut Ibrahim,KAR FATİH,ŞENAT Almila,Duymaz Tomris,EREL Ozcan,Salihoglu Ece Thiol/disulfide homeostasis and oxidant status in children with congenital heart disease. , 2022, ss.23 - 31. 10.1515/tjb-2021-0172
AMA Sogut I,KAR F,ŞENAT A,Duymaz T,EREL O,Salihoglu E Thiol/disulfide homeostasis and oxidant status in children with congenital heart disease. . 2022; 23 - 31. 10.1515/tjb-2021-0172
Vancouver Sogut I,KAR F,ŞENAT A,Duymaz T,EREL O,Salihoglu E Thiol/disulfide homeostasis and oxidant status in children with congenital heart disease. . 2022; 23 - 31. 10.1515/tjb-2021-0172
IEEE Sogut I,KAR F,ŞENAT A,Duymaz T,EREL O,Salihoglu E "Thiol/disulfide homeostasis and oxidant status in children with congenital heart disease." , ss.23 - 31, 2022. 10.1515/tjb-2021-0172
ISNAD Sogut, Ibrahim vd. "Thiol/disulfide homeostasis and oxidant status in children with congenital heart disease". (2022), 23-31. https://doi.org/10.1515/tjb-2021-0172
APA Sogut I, KAR F, ŞENAT A, Duymaz T, EREL O, Salihoglu E (2022). Thiol/disulfide homeostasis and oxidant status in children with congenital heart disease. Türk Biyokimya Dergisi, 47(3), 23 - 31. 10.1515/tjb-2021-0172
Chicago Sogut Ibrahim,KAR FATİH,ŞENAT Almila,Duymaz Tomris,EREL Ozcan,Salihoglu Ece Thiol/disulfide homeostasis and oxidant status in children with congenital heart disease. Türk Biyokimya Dergisi 47, no.3 (2022): 23 - 31. 10.1515/tjb-2021-0172
MLA Sogut Ibrahim,KAR FATİH,ŞENAT Almila,Duymaz Tomris,EREL Ozcan,Salihoglu Ece Thiol/disulfide homeostasis and oxidant status in children with congenital heart disease. Türk Biyokimya Dergisi, vol.47, no.3, 2022, ss.23 - 31. 10.1515/tjb-2021-0172
AMA Sogut I,KAR F,ŞENAT A,Duymaz T,EREL O,Salihoglu E Thiol/disulfide homeostasis and oxidant status in children with congenital heart disease. Türk Biyokimya Dergisi. 2022; 47(3): 23 - 31. 10.1515/tjb-2021-0172
Vancouver Sogut I,KAR F,ŞENAT A,Duymaz T,EREL O,Salihoglu E Thiol/disulfide homeostasis and oxidant status in children with congenital heart disease. Türk Biyokimya Dergisi. 2022; 47(3): 23 - 31. 10.1515/tjb-2021-0172
IEEE Sogut I,KAR F,ŞENAT A,Duymaz T,EREL O,Salihoglu E "Thiol/disulfide homeostasis and oxidant status in children with congenital heart disease." Türk Biyokimya Dergisi, 47, ss.23 - 31, 2022. 10.1515/tjb-2021-0172
ISNAD Sogut, Ibrahim vd. "Thiol/disulfide homeostasis and oxidant status in children with congenital heart disease". Türk Biyokimya Dergisi 47/3 (2022), 23-31. https://doi.org/10.1515/tjb-2021-0172